University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Pain of Conventional to Buffered Local Anesthesia During Injection in Pediatric Dental Patients

Phase 4

Completed

Conditions: Pain

Interventions: Drug: Lidocaine
Drug: Sodium bicarbonate

First Posted Date: 2012-06-19

Last Posted Date: 2014-03-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT01622296

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Therapeutic Hypothermia After the Return of Spontaneous Circulation

Not Applicable

Terminated

Conditions: Cardiac Arrest

Interventions: Other: Induced therapeutic hypothermia

First Posted Date: 2012-06-12

Last Posted Date: 2014-02-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 46

Registration Number: NCT01617291

Locations: 🇺🇸
Community Regional Medical Center, Fresno, California, United States

Delayed Start to Ovarian Stimulation

Phase 4

Terminated

Conditions: Diminished Ovarian Reserve
In Vitro Fertilization
Infertility

Interventions: Drug: Ganirelix acetate

First Posted Date: 2012-06-07

Last Posted Date: 2021-06-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT01614067

Locations: 🇺🇸
UCSF Center for Reproductive Health, San Francisco, California, United States

Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients

Phase 3

Withdrawn

Conditions: Congenital Heart Disease
Fontan

Interventions: Drug: inhaled nitric oxide

First Posted Date: 2012-05-30

Last Posted Date: 2018-05-04

Lead Sponsor: University of California, San Francisco

Registration Number: NCT01607983

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Irrigation Versus no Irrigation for Cutaneous Abscess

Not Applicable

Completed

Conditions: Cutaneous Abscess

Interventions: Procedure: Irrigation
Other: No Irrigation

First Posted Date: 2012-05-28

Last Posted Date: 2017-05-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 201

Registration Number: NCT01606657

Locations: 🇺🇸
Community Regional Trauma and Burn Center, Fresno, California, United States

Healthy Mood Internet Recruitment Study

Not Applicable

Completed

Conditions: Recruitment

Interventions: Behavioral: Healthy Mood Project Website

First Posted Date: 2012-05-28

Last Posted Date: 2015-05-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1226

Registration Number: NCT01607164

Locations: 🇺🇸
UCSF Psychiatry at San Francisco General Hospital, San Francisco, California, United States

Effects of Brain Beta-Amyloid on Postoperative Cognition

Phase 4

Recruiting

Conditions: Postoperative Cognitive Dysfunction

Interventions: Drug: Florbetapir F 18 (18F-AV-45)
Other: no intervention

First Posted Date: 2012-05-25

Last Posted Date: 2022-12-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 100

Registration Number: NCT01606488

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States

Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring

Completed

Conditions: Blood Loss

First Posted Date: 2012-05-24

Last Posted Date: 2013-08-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT01604668

Locations: 🇺🇸
University of California, San Francisco Moffitt/Long Hospitals, San Francisco, California, United States

Endothelial Function and Arterio-Venous Fistula Maturation

Completed

Conditions: Chronic Kidney Disease

First Posted Date: 2012-05-23

Last Posted Date: 2022-09-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 54

Registration Number: NCT01604473

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States
🇺🇸
University of California, San Francisco Medical Center, San Francisco, California, United States

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Phase 2

Terminated

Conditions: Myeloid Malignancy
Bone Marrow Failure Syndrome
Severe Immune Dysregulation
Metabolic Disease
Transfusion-dependent Red Blood Cell (RBC) Defect
Congenital Immunodeficiency

Interventions: Drug: Busulfan
Drug: Alemtuzumab
Drug: Fludarabine
Drug: Clofarabine

First Posted Date: 2012-05-11

Last Posted Date: 2020-02-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 16

Registration Number: NCT01596699

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy